Annual SG&A:
$0.00-$30.05M(-100.00%)Summary
- As of today, TSHA annual SG&A is $0.00, with the most recent change of -$30.05 million (-100.00%) on December 31, 2024.
- During the last 3 years, TSHA annual SG&A has fallen by -$41.32 million (-100.00%).
- TSHA annual SG&A is now -100.00% below its all-time high of $41.32 million, reached on December 31, 2021.
Performance
TSHA SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$8.28M-$319.00K(-3.71%)Summary
- As of today, TSHA quarterly SG&A is $8.28 million, with the most recent change of -$319.00 thousand (-3.71%) on September 30, 2025.
- Over the past year, TSHA quarterly SG&A has increased by +$377.00 thousand (+4.77%).
- TSHA quarterly SG&A is now -29.87% below its all-time high of $11.81 million, reached on December 31, 2021.
Performance
TSHA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$2.56B-$99.93M(-4.06%)Summary
- As of today, TSHA TTM SG&A is -$2.56 billion, with the most recent change of -$99.93 million (-4.06%) on September 30, 2025.
- Over the past year, TSHA TTM SG&A has dropped by -$2.59 billion (-8915.56%).
- TSHA TTM SG&A is now -9121.00% below its all-time high of -$27.77 million.
Performance
TSHA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
TSHA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -100.0% | +4.8% | -8915.6% |
| 3Y3 Years | -100.0% | -4.7% | -6221.5% |
| 5Y5 Years | -100.0% | +107.8% | -10000.0% |
TSHA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -100.0% | at low | -5.4% | +38.3% | -115.7% | at low |
| 5Y | 5-Year | -100.0% | at low | -29.9% | +107.8% | -3527.8% | at low |
| All-Time | All-Time | -100.0% | at low | -29.9% | >+9999.0% | -9121.0% | at low |
TSHA Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $8.28M(-3.7%) | $31.66M(+1.2%) |
| Jun 2025 | - | $8.60M(+5.4%) | $31.29M(+4.2%) |
| Mar 2025 | - | $8.16M(+23.1%) | $30.03M(+3.7%) |
| Dec 2024 | $0.00(-100.0%) | $6.63M(-16.1%) | $28.95M(-0.3%) |
| Sep 2024 | - | $7.90M(+7.7%) | $29.04M(-2.3%) |
| Jun 2024 | - | $7.34M(+3.6%) | $29.73M(+4.8%) |
| Mar 2024 | - | $7.08M(+5.4%) | $28.38M(-5.5%) |
| Dec 2023 | $30.05M(-19.6%) | $6.72M(-21.8%) | $30.05M(-2.0%) |
| Sep 2023 | - | $8.59M(+43.4%) | $30.67M(-0.3%) |
| Jun 2023 | - | $5.99M(-31.6%) | $30.76M(-11.2%) |
| Mar 2023 | - | $8.75M(+19.2%) | $34.64M(-7.3%) |
| Dec 2022 | $37.36M | $7.34M(-15.5%) | $37.36M(-10.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $8.68M(-12.0%) | $41.83M(-5.6%) |
| Jun 2022 | - | $9.87M(-14.0%) | $44.30M(-0.6%) |
| Mar 2022 | - | $11.47M(-2.9%) | $44.56M(+7.8%) |
| Dec 2021 | $41.32M(+272.0%) | $11.81M(+5.9%) | $41.32M(+16.0%) |
| Sep 2021 | - | $11.15M(+10.1%) | $35.63M(+25.2%) |
| Jun 2021 | - | $10.13M(+23.0%) | $28.46M(+55.3%) |
| Mar 2021 | - | $8.24M(+34.9%) | $18.33M(+80.4%) |
| Dec 2020 | $11.11M(+8578.9%) | - | - |
| Dec 2020 | - | $6.11M(+53.3%) | $10.16M(+143.0%) |
| Sep 2020 | - | $3.98M(+5591.4%) | $4.18M(+2012.1%) |
| Mar 2020 | - | $70.00K(-45.3%) | $198.00K(+54.7%) |
| Dec 2019 | $128.00K | - | - |
| Dec 2019 | - | $128.00K | $128.00K |
FAQ
- What is Taysha Gene Therapies, Inc. annual SG&A?
- What is the all-time high annual SG&A for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. annual SG&A year-on-year change?
- What is Taysha Gene Therapies, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. quarterly SG&A year-on-year change?
- What is Taysha Gene Therapies, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. TTM SG&A year-on-year change?
What is Taysha Gene Therapies, Inc. annual SG&A?
The current annual SG&A of TSHA is $0.00
What is the all-time high annual SG&A for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high annual SG&A is $41.32M
What is Taysha Gene Therapies, Inc. annual SG&A year-on-year change?
Over the past year, TSHA annual SG&A has changed by -$30.05M (-100.00%)
What is Taysha Gene Therapies, Inc. quarterly SG&A?
The current quarterly SG&A of TSHA is $8.28M
What is the all-time high quarterly SG&A for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high quarterly SG&A is $11.81M
What is Taysha Gene Therapies, Inc. quarterly SG&A year-on-year change?
Over the past year, TSHA quarterly SG&A has changed by +$377.00K (+4.77%)
What is Taysha Gene Therapies, Inc. TTM SG&A?
The current TTM SG&A of TSHA is -$2.56B
What is the all-time high TTM SG&A for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high TTM SG&A is -$27.77M
What is Taysha Gene Therapies, Inc. TTM SG&A year-on-year change?
Over the past year, TSHA TTM SG&A has changed by -$2.59B (-8915.56%)